Our vision is to continuously deliver innovative therapeutic drugs that will significantly improve the health of patients.



  • Quarterly information - Fourth quarter 2014

    27/02/2015 - Turnover up 10% compared to 2013 Fourth quarter


  • Masitinib in Alzheimer's disease - Web Conference Audio Recording

    16/02/2015 - This web conference was held on 13th February 2015


  • Masitinib in Asthma - Web Conference Audio Recording

    16/02/2015 - This web conference was held on 2nd December 2015


  • Masitinib in Mastocytosis - Web Conference Audio Recording

    16/02/2015 - This web conference was held on 7th November 2014


  • Web conference - Masitinib in Alzheimer's disease

    10/02/2015 - Safety and efficacy update